Thomas R. Kuhn - Jan 2, 2024 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Director, Vice Chairman
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
1/4/2024, 05:52 PM
Previous filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock Award $0 +3.9K $0.00 3.9K Jan 2, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +59K $0.00 59K Jan 2, 2024 Common Stock 59K $33.62 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock vests in full on August 7, 2024.
F2 Options awarded in connection with director's appointment to the Board as Vice Chairman. For further information see the Anterix Inc. Form 8-K filed with the Securities Exchange Commission on January 4, 2024.
F3 1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter.